Td Asset Management Inc Crispr Therapeutics Ag Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

A detailed history of Td Asset Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Td Asset Management Inc holds 240,444 shares of CRSP stock, worth $12.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

240,444

Previous 159,644 50.61%

Holding current value

$12.6 Million

Previous $7.5 Million 26.16%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$38.65 - $55.15 $3.12 Million - $4.46 Million	80,800 Added 50.61%	240,444 $9.46 Million
Q2 2024 Aug 02, 2024	SELL	$51.17 - $68.18 $365,865 - $487,487	-7,150 Reduced 4.29%	159,644 $8.62 Million
Q1 2024 May 08, 2024	SELL	$60.67 - $89.12 $3.58 Million - $5.26 Million	-59,068 Reduced 26.15%	166,794 $11.4 Million
Q4 2023 Feb 12, 2024	SELL	$38.62 - $72.18 $563,852 - $1.05 Million	-14,600 Reduced 6.07%	225,862 $14.1 Million
Q3 2023 Oct 27, 2023	BUY	$45.39 - $59.0 $1.24 Million - $1.62 Million	27,387 Added 12.85%	240,462 $10.9 Million
Q2 2023 Aug 09, 2023	BUY	$43.47 - $67.77 $133,409 - $207,986	3,069 Added 1.46%	213,075 $12 Million
Q1 2023 May 10, 2023	BUY	$41.0 - $56.12 $1.16 Million - $1.58 Million	28,179 Added 15.5%	210,006 $9.5 Million
Q4 2022 Feb 06, 2023	BUY	$39.19 - $65.67 $2.61 Million - $4.37 Million	66,536 Added 57.71%	181,827 $7.39 Million
Q3 2022 Nov 07, 2022	BUY	$61.1 - $83.78 $710,593 - $974,361	11,630 Added 11.22%	115,291 $7.44 Million
Q2 2022 Aug 04, 2022	BUY	$43.23 - $73.83 $3.1 Million - $5.29 Million	71,636 Added 223.69%	103,661 $6.3 Million
Q1 2022 May 10, 2022	SELL	$53.19 - $79.24 $119,571 - $178,131	-2,248 Reduced 6.56%	32,025 $2.01 Million
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $271,668 - $431,360	3,876 Added 12.75%	34,273 $2.6 Million
Q2 2021 Aug 11, 2021	SELL	$100.84 - $161.89 $100,739 - $161,728	-999 Reduced 3.18%	30,397 $3.68 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $34,544 - $65,532	-312 Reduced 0.98%	31,396 $3.83 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $2.53 Million - $5.49 Million	31,708 New	31,708 $4.86 Million

Others Institutions Holding CRSP

# of Institutions

487

Shares Held

64.2M

Call Options Held

1.66M

Put Options Held

1.99M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.07B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Crispr Therapeutics Ag Transaction History